vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $7.8M, roughly 9.7× CRYO CELL INTERNATIONAL INC). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -48.7%, a 56.1% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -2.3%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $1.2M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -0.1%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
CCEL vs VMD — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $76.2M |
| Net Profit | $-3.8M | $5.6M |
| Gross Margin | 77.9% | 57.9% |
| Operating Margin | -50.6% | 11.0% |
| Net Margin | -48.7% | 7.4% |
| Revenue YoY | -2.3% | 25.5% |
| Net Profit YoY | -105.1% | 30.7% |
| EPS (diluted) | $-0.46 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $76.2M | ||
| Q3 25 | $7.8M | $71.9M | ||
| Q2 25 | $7.9M | $63.1M | ||
| Q1 25 | $8.0M | $59.1M | ||
| Q4 24 | $8.0M | $60.7M | ||
| Q3 24 | $8.1M | $58.0M | ||
| Q2 24 | $8.0M | $55.0M | ||
| Q1 24 | $7.9M | $50.6M |
| Q4 25 | $-3.8M | $5.6M | ||
| Q3 25 | $749.4K | $3.5M | ||
| Q2 25 | $355.8K | $3.2M | ||
| Q1 25 | $282.9K | $2.6M | ||
| Q4 24 | $-1.9M | $4.3M | ||
| Q3 24 | $1.1M | $3.9M | ||
| Q2 24 | $655.8K | $1.5M | ||
| Q1 24 | $556.2K | $1.6M |
| Q4 25 | 77.9% | 57.9% | ||
| Q3 25 | 77.0% | 57.5% | ||
| Q2 25 | 76.6% | 58.3% | ||
| Q1 25 | 75.1% | 56.3% | ||
| Q4 24 | 78.4% | 59.5% | ||
| Q3 24 | 73.6% | 59.3% | ||
| Q2 24 | 74.8% | 59.8% | ||
| Q1 24 | 73.7% | 58.9% |
| Q4 25 | -50.6% | 11.0% | ||
| Q3 25 | 24.3% | 7.8% | ||
| Q2 25 | 18.8% | 8.1% | ||
| Q1 25 | 13.3% | 6.5% | ||
| Q4 24 | -1.5% | 10.6% | ||
| Q3 24 | 17.2% | 9.7% | ||
| Q2 24 | 17.3% | 6.6% | ||
| Q1 24 | 10.5% | 4.4% |
| Q4 25 | -48.7% | 7.4% | ||
| Q3 25 | 9.6% | 4.9% | ||
| Q2 25 | 4.5% | 5.0% | ||
| Q1 25 | 3.5% | 4.4% | ||
| Q4 24 | -23.2% | 7.1% | ||
| Q3 24 | 13.0% | 6.7% | ||
| Q2 24 | 8.2% | 2.7% | ||
| Q1 24 | 7.1% | 3.2% |
| Q4 25 | $-0.46 | $0.14 | ||
| Q3 25 | $0.09 | $0.09 | ||
| Q2 25 | $0.04 | $0.08 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.23 | $0.10 | ||
| Q3 24 | $0.13 | $0.10 | ||
| Q2 24 | $0.08 | $0.04 | ||
| Q1 24 | $0.07 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $13.5M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $141.5M |
| Total Assets | $61.7M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $13.5M | ||
| Q3 25 | $3.2M | $11.1M | ||
| Q2 25 | $4.4M | $20.0M | ||
| Q1 25 | $3.5M | $10.2M | ||
| Q4 24 | $3.5M | $17.5M | ||
| Q3 24 | $2.1M | $11.3M | ||
| Q2 24 | $1.5M | $8.8M | ||
| Q1 24 | $979.6K | $7.3M |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $141.5M | ||
| Q3 25 | $-14.8M | $133.6M | ||
| Q2 25 | $-15.6M | $139.7M | ||
| Q1 25 | $-14.7M | $134.8M | ||
| Q4 24 | $-13.2M | $131.4M | ||
| Q3 24 | $-9.6M | $125.0M | ||
| Q2 24 | $-10.7M | $119.4M | ||
| Q1 24 | $-10.3M | $116.3M |
| Q4 25 | $61.7M | $199.2M | ||
| Q3 25 | $63.2M | $202.4M | ||
| Q2 25 | $64.4M | $184.6M | ||
| Q1 25 | $64.4M | $178.1M | ||
| Q4 24 | $64.7M | $177.1M | ||
| Q3 24 | $62.9M | $169.5M | ||
| Q2 24 | $62.6M | $163.9M | ||
| Q1 24 | $61.7M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $18.4M |
| Free Cash FlowOCF − Capex | $1.2M | $9.7M |
| FCF MarginFCF / Revenue | 15.5% | 12.7% |
| Capex IntensityCapex / Revenue | 0.9% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $18.4M | ||
| Q3 25 | $2.5M | $18.4M | ||
| Q2 25 | $707.0K | $12.3M | ||
| Q1 25 | $954.1K | $2.9M | ||
| Q4 24 | $2.2M | $15.0M | ||
| Q3 24 | $2.4M | $12.7M | ||
| Q2 24 | $1.8M | $10.2M | ||
| Q1 24 | $-356.9K | $1.2M |
| Q4 25 | $1.2M | $9.7M | ||
| Q3 25 | $2.5M | $10.7M | ||
| Q2 25 | $644.6K | $4.1M | ||
| Q1 25 | $892.0K | $-12.6M | ||
| Q4 24 | $2.1M | $3.2M | ||
| Q3 24 | $2.3M | $1.7M | ||
| Q2 24 | $21.5K | $1.2M | ||
| Q1 24 | $-814.6K | $-4.8M |
| Q4 25 | 15.5% | 12.7% | ||
| Q3 25 | 31.9% | 14.9% | ||
| Q2 25 | 8.1% | 6.5% | ||
| Q1 25 | 11.2% | -21.4% | ||
| Q4 24 | 26.8% | 5.2% | ||
| Q3 24 | 27.9% | 3.0% | ||
| Q2 24 | 0.3% | 2.3% | ||
| Q1 24 | -10.4% | -9.5% |
| Q4 25 | 0.9% | 11.5% | ||
| Q3 25 | 0.5% | 10.6% | ||
| Q2 25 | 0.8% | 12.9% | ||
| Q1 25 | 0.8% | 26.2% | ||
| Q4 24 | 0.1% | 19.5% | ||
| Q3 24 | 2.3% | 19.0% | ||
| Q2 24 | 21.8% | 16.3% | ||
| Q1 24 | 5.8% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | 3.38× | 5.23× | ||
| Q2 25 | 1.99× | 3.88× | ||
| Q1 25 | 3.37× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 2.32× | 3.29× | ||
| Q2 24 | 2.70× | 6.94× | ||
| Q1 24 | -0.64× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
